Below, we guide you through the five primary Greeks—delta, gamma, theta, vega, and rho—explaining what each tells you, how they interact, and why they matter when you're trading options.

Beyond Air receives 180-day extension from Nasdaq to regain compliance with minimum bid price requirement for its common stock. Beyond Air, Inc. announced that it has received a 180-day extension ...

The Company did not regain compliance with the minimum $1.00 bid price per share requirement during the first 180 calendar day compliance period and submitted a written request to Nasdaq’s staff to ...

Liverpool had no hesitation blocking a deadline day offer from Middlesbrough for Tyler Morton, with a trusted source revealing the minimum valuation the Reds were demanding – though there was ...

KKR currently has a 33.97% stake in Fuji Soft following the first stage of a two-part bid in which two activist investors - 3D Investment Partners and Farallon Capital - agreed to tender their ...

Meanwhile, the Reds are not expecting any late move from Real Madrid on transfer deadline day for Alexander-Arnold after the Champions League holders had an approach rejected late last month.

There were winners all over the park for Sunderland on this day. Neil Martin and Nic Sharkey had been a constant threat and Allan Gauden had shown enough to warrant another opportunity.

The data will be shared during an R&D Update Day to be held today at 11am ET; registration for the event and further information are available at https://alpha-tau-medical-2025-rd-day.open ...

A look at the day ahead in European and global markets from Tom Westbrook The exceptionalism that drove Wall Street to record highs on the back of America's peerless technology firms suddenly has ...

Beacon verified, later that day, that its Board of Directors “thoroughly evaluated” and unanimously rejected that “unsolicited, non-binding” proposal from QXO. On Jan. 27, QXO announced a more ...

- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of Alpha DaRT ®- - Ad-hoc analyses of pancreatic cancer ...